1. Home
  2. GOSS vs ETD Comparison

GOSS vs ETD Comparison

Compare GOSS & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$0.50

Market Cap

615.7M

Sector

Health Care

ML Signal

N/A

Logo Ethan Allen Interiors Inc.

ETD

Ethan Allen Interiors Inc.

N/A

Current Price

$22.16

Market Cap

624.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
GOSS
ETD
Founded
2015
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
615.7M
624.5M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
GOSS
ETD
Price
$0.50
$22.16
Analyst Decision
Buy
Hold
Analyst Count
9
1
Target Price
$4.91
$27.00
AVG Volume (30 Days)
27.3M
303.4K
Earning Date
01-01-0001
04-28-2026
Dividend Yield
N/A
8.14%
EPS Growth
78.81
N/A
EPS
N/A
0.87
Revenue
$114,701,000.00
$766,784,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.73
P/E Ratio
N/A
$25.54
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$21.67
52 Week High
$3.87
$31.41

Technical Indicators

Market Signals
Indicator
GOSS
ETD
Relative Strength Index (RSI) 23.06 36.13
Support Level $0.33 $21.67
Resistance Level $1.23 $25.12
Average True Range (ATR) 0.09 0.55
MACD -0.00 -0.09
Stochastic Oscillator 8.98 29.87

Price Performance

Historical Comparison
GOSS
ETD

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

Share on Social Networks: